Specified development authority income receives retrospective tax exemption, subject to non-commercial activity, unchanged income sources, and return-...
Unified Brand India framework introduces voluntary Trust Mark certification and funding support for export branding, packaging and global promotional ...
Origin Declaration authentication governs preferential tariff claims under India-UK CETA, requiring a validated reference number before import clearan...
Separate assessment orders for different years remain valid when distinct notices and hearing opportunities prevent prejudice from combined proceeding...
Defined public benefit can retain charitable character; registration renewal requires examining genuine activities and legal compliance, not surplus a...
Capital reduction is distinct from share buy-back, preventing buy-back tax; restructuring interest and related business deductions also survive scruti...
Finality of an earlier judicial determination prevented the Department from reopening the applicable compounding guidelines when calculating the compounding fee. The article explains that a direction to quantify the fee required calculation rather than fresh adjudication, and that statutory instructions on compounding could not displace a binding inter partes finding that the 2008 CBDT Guidelines governed the application. It further notes that the 2024 Guidelines on fresh applications were limited to applications rejected for specified curable defects and did not cover applications rejected on merits. The fee was therefore to be recomputed under the 2008 Guidelines after crediting the amount already paid.
Finality of an earlier judicial determination prevented the Department from reopening the applicable compounding guidelines when calculating the compounding fee. The article explains that a direction to quantify the fee required calculation rather than fresh adjudication, and that statutory instructions on compounding could not displace a binding inter partes finding that the 2008 CBDT Guidelines governed the application. It further notes that the 2024 Guidelines on fresh applications were limited to applications rejected for specified curable defects and did not cover applications rejected on merits. The fee was therefore to be recomputed under the 2008 Guidelines after crediting the amount already paid.
Note: It is a system-generated summary and is for quick reference only.